PELEUS

Dead / Cancelled — Cancelled — Section 8 (as of 21 Nov 2025)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
87850414
Registration number
5743057
Mark type
Stylized text
Filed
26 Mar 2018
Published for opposition
19 Feb 2019
Registered
07 May 2019
Attorney of record
Mark Harrison

Goods and services

  • Class 005 — Pharmaceuticals: Medical and veterinary preparations for therapeutic purposes namely, pharmaceutical and veterinary preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; pharmaceutical products for the diagnosis, prevention and treatment of cancer; pharmaceutical preparations for cancer therapy; antibodies being pharmaceutical preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; vaccines; pharmaceutical preparations for cell therapy; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes
  • Class 009 — Scientific and electric apparatus: Bioinformatics software for sequence data analysis; computer software platforms for sequence data analysis in the fields of cancer evolution and new cancer therapies, immune response disorders, genetic conditions, infectious diseases and vascular disease
  • Class 040 — Treatment of materials: Custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies
  • Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies; and research and design relating thereto; industrial analysis and research services in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services involving the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research into cancer evolution and clonal architecture; scientific research in human and animal cell therapy; scientific research into vaccines; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; providing software as a service for the identification of clonal neo-antigens; providing a bioinformatics platform as a service (PAAS) featuring computer software for sequence data analysis in the field of manufacturing therapeutics; providing a bioinformatics platform featuring computer software for identifying clonal neoantigens
  • Class 044 — Medical, beauty and agricultural services: Medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies

Owner

Prosecution history

  • 21 Nov 2025 — CANCELLED SEC. 8 (6-YR)
  • 07 May 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 04 Aug 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 07 May 2019 — REGISTERED-PRINCIPAL REGISTER
  • 19 Feb 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 19 Feb 2019 — PUBLISHED FOR OPPOSITION
  • 30 Jan 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 01 Jan 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 28 Dec 2018 — EXAMINER'S AMENDMENT ENTERED
  • 28 Dec 2018 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 28 Dec 2018 — EXAMINERS AMENDMENT E-MAILED
  • 28 Dec 2018 — EXAMINERS AMENDMENT -WRITTEN
  • 24 Dec 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 24 Dec 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 24 Dec 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED

View this trademark record on Marksy